News

Cerner, Qualcomm, home health monitoring, 2net, CareAware, EHR

Cerner Corp. and Qualcomm Life Inc. announced an agreement to extend Cerner’s medical device connectivity capabilities beyond the hospital to the home. Cerner will leverage Qualcomm Life’s U.S....

ivabradine (Corlanor)

The U.S. Food and Drug Administration (FDA) approved Amgen’s ivabradine (Corlanor) to reduce hospitalization from worsening heart failure.

CareDx Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high-value, non-invasive surveillance solutions for transplant...

PatientPoint announced that PatientPoint Outreach 3.2 is now certified for Meaningful Use in an ambulatory setting. The software is also compliant with the Office of the National Coordinator (ONC...

SynCardia, Total Artificial Heart, 50cc, FDA, investigational study

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia...

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug,...

Bendavia, heart attack, scarring, angioplasty, ACC, study

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a...

heart failure, BAT, baroreflex activation therapy, William Abraham, CVRx

Results of a clinical trial announced at the American College of Cardiology Annual Scientific Session show a new type of therapy is safe and effective for symptomatic advanced heart...

ST2, cardiac biomarker, Critical Diagnostics, heart failure, predict outcomes

According to an abstract presented at the American College of Cardiology (ACC) Scientific Sessions in San Diego, elevated levels of the cardiac biomarker ST2 were associated with an increased risk...

St. Jude, CardioMEMS, CHAMPION trial, heart failure, reduced ejection fraction

Heart failure patients with reduced ejection fraction experienced significant HF mortality and hospitalization reductions via guideline-directed medical therapy managed by pulmonary artery...

Critical Diagnostics announced it has expanded its cardiac biomarker testing product portfolio by CE marking the Aspect-PLUS ST2 test, a rapid quantitative ST2 test. Results are reported in under...

protein, heart failure, trial, RBFox2, cardiac diagnostics, UC San Diego

Researchers at the University of California, San Diego School of Medicine have identified a key piece in the complex molecular puzzle underlying heart failure.

ACC, Guideline App, prevention, atrial fibrillation, clinical decision support

The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full...

Sunshine Heart, C-Pulse, COUNTER HF, study, FDA, heart failure

Sunshine Heart Inc. announced it has received unconditional approval from the U.S. Food and Drug Administration (FDA) to conduct an interim analysis of COUNTER HF, the company's U.S. pivotal study...

Stronger Hearts Helpline, heart failure, telecardiology, California

The National Forum for Heart Disease & Stroke Prevention announced the launch of the Stronger Hearts Helpline, a 24/7 free call-center resource for people with heart failure and...

Quadripolar lead, Medtronic, Attain, VivaQuad, CRT-D

There have been several recent advancements in implantable cardioverter defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Yale, CORE, IV fluids, diuretics, heart failure, study

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a Yale-led study has found.

Heart failure, remote monitoring, CardioMEMS, St. Jude Medical

Swedish Medical Center is the first facility in the Rocky Mountain Region to implant a new miniaturized, wireless monitoring sensor to manage heart failure (HF).

Case Western Reserve’s chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack.